HOTCHKIS & WILEY's MDT Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 5.82 M shares of Medtronic plc (MDT) worth $554.49 M, representing 1.71% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, HOTCHKIS & WILEY has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2022, adding 1.47 M shares. Largest reduction occurred in Q1 2016, reducing 1.51 M shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's Medtronic plc (MDT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medtronic plc (MDT) Trades by HOTCHKIS & WILEY
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +5.75 M | New Buy | 5.75 M | $77.99 |
| Q2 2015 | -133,508 | Reduce 2.32% | 5.62 M | $74.10 |
| Q3 2015 | -329,058 | Reduce 5.86% | 5.29 M | $66.94 |
| Q4 2015 | -1.41 M | Reduce 26.64% | 3.88 M | $76.92 |
| Q1 2016 | -1.51 M | Reduce 38.83% | 2.37 M | $75.00 |
| Q2 2016 | -720,349 | Reduce 30.34% | 1.65 M | $86.77 |
| Q3 2016 | -640,730 | Reduce 38.75% | 1.01 M | $86.40 |
| Q4 2016 | +238,419 | Add 23.54% | 1.25 M | $71.23 |
| Q1 2017 | -15,554 | Reduce 1.24% | 1.24 M | $80.56 |
| Q2 2017 | +991,800 | Add 80.26% | 2.23 M | $88.75 |
| Q3 2017 | +9,200 | Add 0.41% | 2.24 M | $77.77 |
| Q4 2017 | +244,100 | Add 10.91% | 2.48 M | $80.75 |
| Q1 2018 | +1.38 M | Add 55.70% | 3.86 M | $80.22 |
| Q2 2018 | -235,200 | Reduce 6.09% | 3.63 M | $85.61 |
| Q3 2018 | -443,726 | Reduce 12.23% | 3.18 M | $98.37 |
| Q4 2018 | -452,295 | Reduce 14.21% | 2.73 M | $90.96 |
| Q1 2019 | +1.39 M | Add 50.74% | 4.12 M | $91.08 |
| Q2 2019 | +487,742 | Add 11.85% | 4.61 M | $97.39 |
| Q3 2019 | -666,230 | Reduce 14.47% | 3.94 M | $108.62 |
| Q4 2019 | +373,706 | Add 9.49% | 4.31 M | $113.45 |
| Q1 2020 | -140,910 | Reduce 3.27% | 4.17 M | $90.18 |
| Q2 2020 | +34,865 | Add 0.84% | 4.21 M | $91.70 |
| Q3 2020 | -445,652 | Reduce 10.59% | 3.76 M | $103.92 |
| Q4 2020 | +49,950 | Add 1.33% | 3.81 M | $117.14 |
| Q1 2021 | -105,000 | Reduce 2.76% | 3.71 M | $118.13 |
| Q2 2021 | -650,982 | Reduce 17.57% | 3.06 M | $124.13 |
| Q3 2021 | -117,250 | Reduce 3.84% | 2.94 M | $125.35 |
| Q4 2021 | +301,230 | Add 10.25% | 3.24 M | $103.45 |
| Q1 2022 | -340,840 | Reduce 10.52% | 2.9 M | $110.95 |
| Q2 2022 | -243,243 | Reduce 8.39% | 2.65 M | $89.75 |
| Q3 2022 | -46,500 | Reduce 1.75% | 2.61 M | $80.75 |
| Q4 2022 | +1.47 M | Add 56.35% | 4.08 M | $77.72 |
| Q1 2023 | +489,710 | Add 12.01% | 4.57 M | $80.62 |
| Q2 2023 | +405,930 | Add 8.89% | 4.97 M | $88.10 |
| Q3 2023 | -55,480 | Reduce 1.12% | 4.92 M | $78.36 |
| Q4 2023 | +1.32 M | Add 26.81% | 6.24 M | $82.38 |
| Q1 2024 | +1.01 M | Add 16.12% | 7.24 M | $87.15 |
| Q2 2024 | -63,124 | Reduce 0.87% | 7.18 M | $78.71 |
| Q3 2024 | -396,725 | Reduce 5.53% | 6.78 M | $90.03 |
| Q4 2024 | +838,082 | Add 12.36% | 7.62 M | $79.88 |
| Q1 2025 | -1.39 M | Reduce 18.27% | 6.23 M | $89.86 |
| Q2 2025 | -296,385 | Reduce 4.76% | 5.93 M | $87.17 |
| Q3 2025 | -109,934 | Reduce 1.85% | 5.82 M | $95.24 |
HOTCHKIS & WILEY's Medtronic plc Investment FAQs
HOTCHKIS & WILEY first purchased Medtronic plc (MDT) in Q1 2015, acquiring 5,753,016 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held Medtronic plc (MDT) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY's largest addition to Medtronic plc (MDT) was in Q1 2015, adding 5,753,016 shares worth $448.68 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 5,821,987 shares of Medtronic plc (MDT), valued at approximately $554.49 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Medtronic plc (MDT) represents approximately 1.71% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY's peak holding in Medtronic plc (MDT) was 7,620,532 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.